Inhaled insulin: new formulation, new trial

Clifford J. Bailey; Anthony H. Barnett

doi:10.1016/S0140-6736(10)60885-9

Inhaled insulin: new formulation, new trial

Clifford J. Bailey
, Anthony H. Barnett

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

Original language	English
Pages (from-to)	2199-201
Number of pages	3
Journal	The Lancet
Volume	375
Issue number	9733
Early online date	24 Jun 2010
DOIs	https://doi.org/10.1016/S0140-6736(10)60885-9
Publication status	Published - 26 Jun 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

inhalation administration
type 2 diabetes mellitus
drug administration schedule
eating
glycosylated hemoglobin A
humans
hypoglycemic agents
subcutaneous injections
insulin
powders

Access to Document

10.1016/S0140-6736(10)60885-9

Cite this

@article{b90dbfba089641b1b99cf31adebaba0a,

title = "Inhaled insulin: new formulation, new trial",

keywords = "inhalation administration, type 2 diabetes mellitus, drug administration schedule, eating, glycosylated hemoglobin A, humans, hypoglycemic agents, subcutaneous injections, insulin, powders",

author = "Bailey, \{Clifford J.\} and Barnett, \{Anthony H.\}",

year = "2010",

month = jun,

day = "26",

doi = "10.1016/S0140-6736(10)60885-9",

language = "English",

volume = "375",

pages = "2199--201",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9733",

}

TY - JOUR

T1 - Inhaled insulin

T2 - new formulation, new trial

AU - Bailey, Clifford J.

AU - Barnett, Anthony H.

PY - 2010/6/26

Y1 - 2010/6/26

KW - inhalation administration

KW - type 2 diabetes mellitus

KW - drug administration schedule

KW - eating

KW - glycosylated hemoglobin A

KW - humans

KW - hypoglycemic agents

KW - subcutaneous injections

KW - insulin

KW - powders

UR - https://www.scopus.com/pages/publications/77953866837

U2 - 10.1016/S0140-6736(10)60885-9

DO - 10.1016/S0140-6736(10)60885-9

M3 - Letter, comment/opinion or interview

C2 - 20609958

SN - 0140-6736

VL - 375

SP - 2199

EP - 2201

JO - The Lancet

JF - The Lancet

IS - 9733

ER -

Inhaled insulin: new formulation, new trial

UN SDGs

Keywords

Access to Document

Other files and links

Cite this